Journal of Medical Economics

Papers
(The H4-Index of Journal of Medical Economics is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Cost-effectiveness of wastewater and environmental monitoring of respiratory syncytial virus to guide universal infant immunoprophylaxis in Canada91
Budget impact model of acellular tissue engineered vessel for the repair of extremity arterial trauma when autologous vein is not feasible56
Economic evaluation of supplemental breast cancer screening modalities to mammography or digital breast tomosynthesis in women with heterogeneously and extremely dense breasts and average or intermedi48
The economic burden of systemic lupus erythematosus in Taiwan47
Socioeconomic effects of establishing a new stroke center in Central Switzerland36
Budget impact of introducing oral semaglutide to the public healthcare benefit package in Saudi Arabia32
Projecting the potential cost-effectiveness of dapagliflozin for chronic kidney disease in Kuwait27
Evaluating the cost-utility of intravesical Bacillus Calmette-Guérin versus radical cystectomy in patients with high-risk non-muscle-invasive bladder cancer in the UK27
Real-world clinical management of individuals with Rett syndrome: a physician survey27
The indirect costs of human papillomavirus-related cancer in Central and Eastern Europe: years of life lost and productivity costs26
Immunization, not vaccination: monoclonal antibodies for infant RSV prevention and the US vaccines for children program25
Improved hospital discharge and cost savings with esophageal cooling during left atrial ablation24
Cost-efficiency analysis of conversion to biosimilar filgrastim for supportive cancer care and resultant expanded access analysis to supportive care and early-stage HER2+ breast cancer treatment in Sa24
Therapeutic innovations: the future of health economics and outcomes research – increasing role of the Asia-Pacific23
Economic evaluations of exome and genome sequencing in pediatric genetics: considerations towards a consensus strategy23
The impact of lurasidone on functioning and indirect costs in adults with bipolar depression: a post-hoc analysis22
Epidemiology and economic burden of Huntington’s disease: a Canadian provincial public health system perspective20
Racial variation in healthcare resource utilization and expenditures in knee/hip osteoarthritis patients: a retrospective analysis of a Medicaid population19
Cost-effectiveness analysis of bimekizumab for the treatment of active psoriatic arthritis in Sweden19
0.071084976196289